ID   SMU-DDCS
AC   CVCL_D1GI
DR   Wikidata; Q127384317
RX   PubMed=37454032;
CC   Population: Japanese.
CC   Doubling time: ~16.8 hours (PubMed=37454032).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (PubMed=37454032).
CC   Derived from site: In situ; Proximal femur, cartilage; UBERON=UBERON_0010129.
ST   Source(s): PubMed=37454032
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 10,12
ST   D16S539: 10,13
ST   D18S51: 13
ST   D21S11: 30,32.2
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 22,23
ST   Penta D: 10
ST   Penta E: 5,18
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C6476; Dedifferentiated chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
RX   PubMed=37454032; DOI=10.1007/s13577-023-00944-0;
RA   Emori M., Nakahashi N., Takasawa A., Murata K., Murahashi Y.,
RA   Shimizu J., Tsukahara T., Sugita S., Takada K., Hasegawa T.,
RA   Osanai M., Iba K.;
RT   "Establishment and characterization of a novel dedifferentiated
RT   chondrosarcoma cell line, SMU-DDCS, harboring an IDH1 mutation.";
RL   Hum. Cell 36:2195-2203(2023).
//